It regulates neurotransmitters, brain function, mood, energy, and hormone levels
Appetite regulation and the role of GLP-1, GIP, and glucagon
These are durable results that matter at a time when published research shows most patients stop GLP-1 therapy within a year
This is your fuel for the first half of the day
Neelakantan and colleagues (Biochem Pharmacol, 2017) then took the pharmacological step, reporting that selective, membrane-permeable small-molecule NNMT inhibitors reversed high-fat-diet-induced obesity in mice this is the study most directly relevant to the 5-Amino-1MQ class, because it moves from the target matters to a drug against the target does something in a live animal. And again, it is a mouse study
Yeah, semaglutide's pretty brutal cost-wise - like $800-1,400 per month without insurance